Terms: = Lung cancer AND IL7R, P16871, IL-7R-alpha, CDW127, CD127, ENSG00000168685, 3575
91 results:
1. Deciphering the heterogeneity of neutrophil cells within circulation and the lung cancer microenvironment pre- and post-operation.
Liu F; Liu X; Liu Y; Chen D; Liu X; Qin C; Song Y; Fang H; Wu D
Cell Biol Toxicol; 2024 Feb; 40(1):11. PubMed ID: 38319415
[TBL] [Abstract] [Full Text] [Related]
2. [Establishment of a 21-color Panel for the Detection of Immune Cell Subsets
in Human Non-small Cell lung cancer Tumor Tissues with Flow Cytometry].
Guo T; Xie H
Zhongguo Fei Ai Za Zhi; 2024 Jan; 27(1):56-64. PubMed ID: 38296626
[TBL] [Abstract] [Full Text] [Related]
3. First-line immunotherapy for lung cancer with MET exon 14 skipping and the relevance of TP53 mutations.
Blasi M; Kuon J; Lüders H; Misch D; Kauffmann-Guerrero D; Hilbrandt M; Kazdal D; Falkenstern-Ge RF; Hackanson B; Dintner S; Faehling M; Kirchner M; Volckmar AL; Kopp HG; Allgäuer M; Grohé C; Tufman A; Reck M; Frost N; Stenzinger A; Thomas M; Christopoulos P
Eur J Cancer; 2024 Mar; 199():113556. PubMed ID: 38271745
[TBL] [Abstract] [Full Text] [Related]
4. Identification of multiple organ metastasis-associated hub mRNA/miRNA signatures in non-small cell lung cancer.
Zu L; He J; Zhou N; Tang Q; Liang M; Xu S
Cell Death Dis; 2023 Dec; 14(12):798. PubMed ID: 38057344
[TBL] [Abstract] [Full Text] [Related]
5. Molecular subtyping based on immune cell marker genes predicts prognosis and therapeutic response in patients with lung adenocarcinoma.
Liu ZT; Shen JT; Lei YJ; Huang YC; Zhao GQ; Zheng CH; Wang X; Wang YT; Chen L; Li ZX; Li SZ; Liao J; Yu TD
BMC Cancer; 2023 Nov; 23(1):1141. PubMed ID: 38001428
[TBL] [Abstract] [Full Text] [Related]
6. Identifying survival of pan-cancer patients under immunotherapy using genomic mutation signature with large sample cohorts.
Zhang L; Wang Y; Wang L; Wang M; Li S; He J; Ji J; Li K; Cao L
J Mol Med (Berl); 2024 Jan; 102(1):69-79. PubMed ID: 37978056
[TBL] [Abstract] [Full Text] [Related]
7. Single-cell mass cytometric analysis of peripheral immunity and multiplex plasma marker profiling of non-small cell lung cancer patients receiving PD-1 targeting immune checkpoint inhibitors in comparison with platinum-based chemotherapy.
Neuperger P; Szalontai K; Gémes N; Balog JÁ; Tiszlavicz L; Furák J; Lázár G; Puskás LG; Szebeni GJ
Front Immunol; 2023; 14():1243233. PubMed ID: 37901220
[TBL] [Abstract] [Full Text] [Related]
8. A Population of Tumor-Infiltrating CD4+ T Cells Co-Expressing CD38 and CD39 Is Associated with Checkpoint Inhibitor Resistance.
Mitra A; Thompson B; Strange A; Amato CM; Vassallo M; Dolgalev I; Hester-McCullough J; Muramatsu T; Kimono D; Puranik AS; Weber JS; Woods D
Clin Cancer Res; 2023 Oct; 29(20):4242-4255. PubMed ID: 37505479
[TBL] [Abstract] [Full Text] [Related]
9. Single-center phase 2 study of PD-1 inhibitor combined with DNA hypomethylation agent + CAG regimen in patients with relapsed/refractory acute myeloid leukemia.
Gao XN; Su YF; Li MY; Jing Y; Wang J; Xu L; Zhang LL; Wang A; Wang YZ; Zheng X; Li YF; Liu DH
Cancer Immunol Immunother; 2023 Aug; 72(8):2769-2782. PubMed ID: 37166484
[TBL] [Abstract] [Full Text] [Related]
10. Meta-analysis of commonly mutated genes in leptomeningeal carcinomatosis.
Congur I; Koni E; Onat OE; Tokcaer Keskin Z
PeerJ; 2023; 11():e15250. PubMed ID: 37096065
[TBL] [Abstract] [Full Text] [Related]
11. Vaccination Ameliorates Cellular Inflammatory Responses in SARS-CoV-2 Breakthrough Infections.
Huapaya JA; Higgins J; Kanth S; Demirkale CY; Gairhe S; Aboye EA; Regenold D; Sahagun SJ; Pastor G; Swaim D; Dewar R; Rehman T; Highbarger HC; Lallemand P; Laverdure S; Adelsberger J; Rupert A; Li W; Krack J; Teferi G; Kuruppu J; Strich JR; Davey R; Childs R; Chertow D; Kovacs JA; Barnett C; Torabi-Parizi P; Suffredini AF;
J Infect Dis; 2023 Jun; 228(1):46-58. PubMed ID: 36801946
[TBL] [Abstract] [Full Text] [Related]
12. Allogeneic cord blood regulatory T cells can resolve lung inflammation.
Lyu MA; Huang M; Zeng K; Li L; Khoury JD; Nishimoto M; Ma H; Sadeghi T; Mukherjee S; Slutsky AS; Flowers CR; Parmar S
Cytotherapy; 2023 Mar; 25(3):245-253. PubMed ID: 36437190
[TBL] [Abstract] [Full Text] [Related]
13. IL-7 is expressed in malignant mesothelioma and has a prognostic value.
Mai HL; Deshayes S; Nguyen TV; Dehame V; Chéné AL; Brouard S; Blanquart C
Mol Oncol; 2022 Oct; 16(20):3606-3619. PubMed ID: 36054746
[TBL] [Abstract] [Full Text] [Related]
14. Correlation between the Treg/Thl7 Index and the Efficacy of PD-1 Monoclonal Antibody in Patients with Advanced Non-Small-Cell lung cancer Complicated with Chronic Obstructive Pulmonary Disease.
Wang X; She X; Gao W; Liu X; Shi B
Comput Math Methods Med; 2022; 2022():2923998. PubMed ID: 35915772
[TBL] [Abstract] [Full Text] [Related]
15. Interleukin 7 inhibit autophagy via P53 regulated AMPK/mTOR signaling pathway in non-small cell lung cancer.
Zhu Y; Jiang X; Ding Z; Ming J
Sci Rep; 2022 Jul; 12(1):11208. PubMed ID: 35778432
[TBL] [Abstract] [Full Text] [Related]
16. Gene network Analysis Defines a Subgroup of Small Cell lung cancer patients With Short Survival.
Cucchiara F; Petrini I; Passaro A; Attili I; Crucitta S; Pardini E; de Marinis F; Danesi R; Del Re M
Clin Lung Cancer; 2022 Sep; 23(6):510-521. PubMed ID: 35739016
[TBL] [Abstract] [Full Text] [Related]
17. Identification of an inflammatory response signature associated with prognostic stratification and drug sensitivity in lung adenocarcinoma.
Song C; Lu Z; Lai K; Li D; Hao B; Xu C; Pan S; Li N; Geng Q
Sci Rep; 2022 Jun; 12(1):10110. PubMed ID: 35710585
[TBL] [Abstract] [Full Text] [Related]
18. Distinct CD8 T Cell Populations with Differential Exhaustion Profiles Associate with Secondary Complications in Common Variable Immunodeficiency.
Klocperk A; Friedmann D; Schlaak AE; Unger S; Parackova Z; Goldacker S; Sediva A; Bengsch B; Warnatz K
J Clin Immunol; 2022 Aug; 42(6):1254-1269. PubMed ID: 35589883
[TBL] [Abstract] [Full Text] [Related]
19. Cell-Free Tumor DNA (ctDNA) Utility in Detection of Original Sensitizing and Resistant EGFR Mutations in Non-Small Cell lung cancer (NSCLC).
Agulnik JS; Papadakis AI; Pepe C; Sakr L; Small D; Wang H; Kasymjanova G; Spatz A; Cohen V
Curr Oncol; 2022 Feb; 29(2):1107-1116. PubMed ID: 35200593
[TBL] [Abstract] [Full Text] [Related]
20. Tumor-infiltrating lymphocytes are functionally inactivated by CD90+ stromal cells and reactivated by combined Ibrutinib and Rapamycin in human pleural mesothelioma.
Yang H; Berezowska S; Dorn P; Zens P; Chen P; Peng RW; Marti TM; Kocher GJ; Schmid RA; Hall SRR
Theranostics; 2022; 12(1):167-185. PubMed ID: 34987640
[No Abstract] [Full Text] [Related]
[Next]
